These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6318112)

  • 1. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.
    Sukumar S; Notario V; Martin-Zanca D; Barbacid M
    Nature; 1983 Dec 15-21; 306(5944):658-61. PubMed ID: 6318112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
    Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
    Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
    Sakai H; Ogawa K
    Int J Cancer; 1991 Aug; 49(1):140-4. PubMed ID: 1874567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA repair in carcinogen-induced ras mutation.
    Engelbergs J; Thomale J; Rajewsky MF
    Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
    Cha RS; Thilly WG; Zarbl H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
    Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
    Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras oncogene activation in mammary carcinomas induced by N-methyl-N-nitrosourea in Copenhagen rats.
    Lu SJ; Archer MC
    Mol Carcinog; 1992; 6(4):260-5. PubMed ID: 1485917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ras oncogenes preceding the onset of neoplasia.
    Kumar R; Sukumar S; Barbacid M
    Science; 1990 Jun; 248(4959):1101-4. PubMed ID: 2188364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for breast cancer.
    Sukumar S; McKenzie K; Chen Y
    Mutat Res; 1995 Dec; 333(1-2):37-44. PubMed ID: 8538634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
    Ronai Z; Lau YY; Cohen LA
    Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
    Thompson TA; Haag JD; Gould MN
    Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased H-ras mutation frequency in mammary tumors of rats initiated with N-methyl-N-nitrosourea (MNU) and treated with acrylamide.
    Cho YM; Imai T; Hasumura M; Watanabe N; Ushijima T; Hirose M; Nishikawa A
    J Toxicol Sci; 2009 Oct; 34(4):407-12. PubMed ID: 19652463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
    Zhang R; Haag JD; Gould MN
    Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis.
    Lu SJ; Archer MC
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1001-5. PubMed ID: 1736280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells.
    Grubbs CJ; Hill DL; McDonough KC; Peckham JC
    J Natl Cancer Inst; 1983 Sep; 71(3):625-8. PubMed ID: 6577237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming c-Ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea.
    Miyamoto S; Sukumar S; Guzman RC; Osborn RC; Nandi S
    Mol Cell Biol; 1990 Apr; 10(4):1593-9. PubMed ID: 2181280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
    Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
    Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.